EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes

Merrick Pierson Smela, Valerio Pepe, Steven Lubbe, Evangelos Kiskinis, George M Church

Stem Cell Reports · 2024

DOI: 10.1016/j.stemcr.2024.08.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cell Reports, 2024. Verfasst von Merrick Pierson Smela und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wyss Institute at Harvard University, Boston MA, USA. Electronic address: mpiersonsmela@g.harvard.edu. Hauptthemen laut MEDLINE: Gene Editing, Software. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NICHD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last decade, advances in genome editing and pluripotent stem cell (PSC) culture have let researchers generate edited PSC lines to study a wide variety of biological questions. However, abnormalities in cell lines such as aneuploidy, mutations, on-target and off-target editing errors, and microbial contamination can arise during PSC culture or due to undesired editing outcomes. The ongoing decline of next-generation sequencing prices has made whole-genome sequencing (WGS) a promising option for detecting these abnormalities. However, this approach has been held back by a lack of easily usable data analysis software. Here, we present SeqVerify, a computational pipeline designed to take raw WGS data and a list of intended genome edits, and verify that the edits are present and that there are no abnormalities. We anticipate that SeqVerify will be a useful tool for researchers generating edited PSCs, and more broadly, for cell line quality control in general.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingSoftwareHumansCell LineGenomicsWhole Genome SequencingHigh-Throughput Nucleotide SequencingAnimalsPluripotent Stem CellsComputational BiologyCRISPR-Cas Systems

Stichwörter der Autor:innen

SeqVerifyaneuploidygenome editingmicrobial contaminationpluripotent stem cellquality controlsingle-nucleotide polymorphismssoftwarestem cellwhole-genome sequencing

Autor:innen und Institutionen

  • Wyss Institute at Harvard University, Boston MA, USA. Electronic address: mpiersonsmela@g.harvard.edu.
  • Wyss Institute at Harvard University, Boston MA, USA.
  • The Ken & Ruth Davee Department of Neurology and Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Simpson Querrey Center of Neurogenetics, Feinberg School of Medicine,…
  • The Ken & Ruth Davee Department of Neurology and Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Wyss Institute at Harvard University, Boston MA, USA; Department of Genetics, Harvard Medical School, Harvard University, Cambridge, MA, USA. Electronic address: george_church@hms.harvard.edu.

Förderung

  • NICHD NIH HHS
  • NICHD

Zitieren

APA

Pierson Smela, M., Pepe, V., Lubbe, S., Kiskinis, E., & Church, G. M. (2024). SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2024.08.004

Vancouver

Pierson Smela M, Pepe V, Lubbe S, Kiskinis E, Church GM. SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes. Stem Cell Reports. 2024. doi:10.1016/j.stemcr.2024.08.004

BibTeX
@article{PiersonSmela2024,
  author = {Pierson Smela, Merrick and Pepe, Valerio and Lubbe, Steven and Kiskinis, Evangelos and Church, George M},
  title = {SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes},
  journal = {Stem Cell Reports},
  year = {2024},
  doi = {10.1016/j.stemcr.2024.08.004}
}
Kostenlos starten →